Hong Seng's subsidiary receives MoH approval on MCO application

KUALA LUMPUR: Hong Seng Consolidated Bhd’s 60-per cent owned subsidiary, eMedAsia Sdn Bhd, today received a letter of approval from the Health Ministry (MOH) regarding its application to carry on the business of a managed care organisation (MCO).

In a filing with Bursa Malaysia today, Hong Seng said a wholesale Type A Licence for the pharmacist working under eMedAsia had been recently approved.

"This allows eMedAsia to import, store and generally deal with all poisons by wholesale and retail or wholesale only in the applied premise, for the period from Jan 11, 2023, to Dec 31, 2023,” it said.

An MCO is any organisation or body with whom a private healthcare facility or service makes a contract or arrangements to provide specified types or quality or quantity of healthcare within a specified financing system and regulated under the provisions in Part XV of the Private Healthcare Facilities and Services Act 1998 (Act 586).

It delivers or gives healthcare to consumers through the MCO’s own healthcare provider or a third-party healthcare provider in accordance with the contract or arrangement between all parties concerned. - Bernama